Details
Stereochemistry | ACHIRAL |
Molecular Formula | C12H11N2O3.Na |
Molecular Weight | 254.2171 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
[Na+].CCC1(C(=O)NC(=O)[N-]C1=O)C2=CC=CC=C2
InChI
InChIKey=WRLGYAWRGXKSKG-UHFFFAOYSA-M
InChI=1S/C12H12N2O3.Na/c1-2-12(8-6-4-3-5-7-8)9(15)13-11(17)14-10(12)16;/h3-7H,2H2,1H3,(H2,13,14,15,16,17);/q;+1/p-1
Molecular Formula | Na |
Molecular Weight | 22.9898 |
Charge | 1 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Molecular Formula | C12H12N2O3 |
Molecular Weight | 232.2353 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 14:59:51 UTC 2023
by
admin
on
Fri Dec 15 14:59:51 UTC 2023
|
Record UNII |
SW9M9BB5K3
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
FDA ORPHAN DRUG |
768420
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
725419
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
725819
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
||
|
NCI_THESAURUS |
C264
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
||
|
NCI_THESAURUS |
C67084
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
||
|
FDA ORPHAN DRUG |
633118
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
DBSALT001491
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
CHEMBL40
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
SW9M9BB5K3
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
12598276
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
100000091098
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
DTXSID0021123
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
4172
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
200-322-3
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
SW9M9BB5K3
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
82077
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | RxNorm | ||
|
C76956
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
SUB09771MIG
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
PHENOBARBITAL SODIUM
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | Description: White, crystalline granules or a white, crystalline powder; odourless. Solubility: Freely soluble in water; soluble in ethanol (~750 g/l) TS; practically insoluble in ether R. Category: Hypnotic; sedative; anticonvulsant. Storage: Phenobarbital sodium should be kept in a tightly closed container, protected from light. Additional information: Phenobarbital sodium is hygroscopic. Even in the absence of light, Phenobarbital sodium is graduallydegraded on exposure to a humid atmosphere, the decomposition being faster at higher temperatures. Definition: Phenobarbital sodium contains not less than 98.0% and not more than 101.0% of C12H11N2NaO3, calculated withreference to the dried substance. | ||
|
m8622
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | Merck Index | ||
|
57-30-7
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY | |||
|
8070
Created by
admin on Fri Dec 15 14:59:52 UTC 2023 , Edited by admin on Fri Dec 15 14:59:52 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
||
|
PARENT -> SALT/SOLVATE |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (HPLC)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
||
|
IMPURITY -> PARENT |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|